TrialLeukemia2024

Long-term outcomes by bone marrow B-cell depletion from the R2W trial of bortezomib with cyclophosphamide and rituximab in Waldenstrőm macroglobulinaemia.

Ruth de Tute et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.